全文获取类型
收费全文 | 961篇 |
免费 | 69篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 30篇 |
基础医学 | 191篇 |
口腔科学 | 4篇 |
临床医学 | 94篇 |
内科学 | 202篇 |
皮肤病学 | 57篇 |
神经病学 | 7篇 |
特种医学 | 8篇 |
外科学 | 48篇 |
综合类 | 53篇 |
预防医学 | 279篇 |
眼科学 | 5篇 |
药学 | 32篇 |
中国医学 | 4篇 |
肿瘤学 | 5篇 |
出版年
2024年 | 2篇 |
2023年 | 17篇 |
2022年 | 57篇 |
2021年 | 77篇 |
2020年 | 34篇 |
2019年 | 43篇 |
2018年 | 36篇 |
2017年 | 37篇 |
2016年 | 52篇 |
2015年 | 63篇 |
2014年 | 62篇 |
2013年 | 65篇 |
2012年 | 48篇 |
2011年 | 75篇 |
2010年 | 58篇 |
2009年 | 53篇 |
2008年 | 27篇 |
2007年 | 31篇 |
2006年 | 21篇 |
2005年 | 25篇 |
2004年 | 21篇 |
2003年 | 16篇 |
2002年 | 16篇 |
2001年 | 8篇 |
2000年 | 14篇 |
1999年 | 5篇 |
1998年 | 9篇 |
1997年 | 7篇 |
1996年 | 9篇 |
1995年 | 6篇 |
1994年 | 9篇 |
1993年 | 7篇 |
1992年 | 12篇 |
1991年 | 2篇 |
1990年 | 1篇 |
1989年 | 1篇 |
1988年 | 2篇 |
1986年 | 1篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1982年 | 2篇 |
1976年 | 1篇 |
排序方式: 共有1035条查询结果,搜索用时 31 毫秒
141.
《Indian journal of medical microbiology》2016,34(2):241-244
Mycobacterium kumamotonense is a novel, slow-growing non-chromogenic nontuberculous mycobacterium, which belongs to Mycobacterium terrae complex. We report, for the first time in Greece, the isolation of M. kumamotonense from an immunocompetent patient with pulmonary infection and latent tuberculosis. M. kumamotonense was identified by sequencing analysis of 16S rDNA and 65-kDa heat shock protein genes while by commercial molecular assays it was misidentified as Mycobacterium celatum. Antibiotic susceptibility testing was performed by the reference broth microdilution method. The strain was susceptible to amikacin, clarithromycin, rifampin, ciprofloxacin, moxifloxacin, rifabutin, ethambutol and linezolid. 相似文献
142.
Alistair Story Richard S. Garfein Andrew Hayward Valiantsin Rusovich Andrei Dadu Viorel Soltan Alexandru Oprunenco Kelly Collins Rohit Sarin Subhi Quraishi Mukta Sharma Giovanni Battista Migliori Maithili Varadarajan Dennis Falzon 《Emerging infectious diseases》2016,22(3):538-540
A recent innovation to help patients adhere to daily tuberculosis (TB) treatment over many months is video (or virtually) observed therapy (VOT). VOT is becoming increasingly feasible as mobile telephone applications and tablet computers become more widely available. Studies of the effectiveness of VOT in improving TB patient outcomes are being conducted. 相似文献
143.
Charlotte L. Kvasnovsky J. Peter Cegielski Martie L. van der Walt 《Emerging infectious diseases》2016,22(9):1529-1536
We analyzed data for a retrospective cohort of patients treated for extensively drug-resistant tuberculosis in 2 provinces in South Africa and compared predictors of treatment outcome in HIV-positive patients who received or had not received antiretroviral drugs with those for HIV-negative patients. Overall, 220 (62.0%) of 355 patients were HIV positive. After 2 years, 34 (10.3%) of 330 patients with a known HIV status and known outcome had a favorable outcome. Multivariate analysis showed that predictors of favorable outcome were negative results for acid-fast bacilli by sputum microscopy at start of treatment and weight >50 kg. HIV-positive patients were more likely to have an unfavorable outcome. The strongest predictor of unfavorable outcome was weight <50 kg. Overall outcomes were poor. HIV status was not a predictor of favorable outcome, but HIV-positive patients were more likely to have an unfavorable outcome. These results underscore the need for timely and adequate treatment for tuberculosis and HIV infection. 相似文献
144.
Beno?t Henry Matthieu Revest Nathalie Dournon Lo?c Epelboin Guillaume Mellon Guillaume Bellaud Pierre Mordant Damien Le D? Nicolas Véziris Christine Bernard Sébastien Morel Stéphane Jauréguiberry Christian Michelet Fran?ois Bricaire Pierre Tattevin éric Caumes 《Emerging infectious diseases》2016,22(3):518-521
We report 20 cases of extensively drug-resistant tuberculosis managed in France. Treatment was individualized and included bedaquiline and linezolid for most patients and surgery in 8 patients. At last follow-up (22 months), 19 patients had achieved conversion from positive to negative on culture testing. These promising results of comprehensive management obtained in a small series deserve confirmation. 相似文献
145.
Aditya Sharma Emily Bloss Charles M. Heilig Eleanor S. Click 《Emerging infectious diseases》2016,22(3):396-403
Mycobacterium africanum is endemic to West Africa and causes tuberculosis (TB). We reviewed reported cases of TB in the United States during 2004–2013 that had lineage assigned by genotype (spoligotype and mycobacterial interspersed repetitive unit variable number tandem repeats). M. africanum caused 315 (0.4%) of 73,290 TB cases with lineage assigned by genotype. TB caused by M. africanum was associated more with persons from West Africa (adjusted odds ratio [aOR] 253.8, 95% CI 59.9–1,076.1) and US-born black persons (aOR 5.7, 95% CI 1.2–25.9) than with US-born white persons. TB caused by M. africanum did not show differences in clinical characteristics when compared with TB caused by M. tuberculosis. Clustered cases defined as >2 cases in a county with identical 24-locus mycobacterial interspersed repetitive unit genotypes, were less likely for M. africanum (aOR 0.1, 95% CI 0.1–0.4), which suggests that M. africanum is not commonly transmitted in the United States. 相似文献
146.
Wan‐Ju Sun Yong‐Jun Liu Hao‐Hao Liu Jie‐De Ma Yu‐Hong Ren Feng‐Qing Wang Dong‐Zhi Wei 《Journal of basic microbiology》2019,59(9):924-935
Some species of mycobacteria have been modified to transform sterols to valuable steroid synthons. The unique cell wall of mycobacteria has been recognized as an important organelle to absorb sterols. Some cell wall inhibitors (e.g., vancomycin and glycine) have been validated to enhance sterol conversion by interfering with transpeptidation in peptidoglycan biosynthesis. Therefore, two transpeptidase genes, pbpA and pbpB, were selected to rationally modify the cell wall to simulate the enhancement effect of vancomycin and glycine on sterol conversion in a 22‐hydroxy‐23,24‐bisnorchol‐4‐ene‐3‐one (4‐HBC) producing strain (WIII). Unexpectedly, the pbpA or pbpB gene augmentation was conducive to the utilization of sterols. The pbpB augmentation strain WIII‐pbpB was further investigated for its better performance. Compared to WIII, the morphology of WIII‐pbpB was markedly changed from oval to spindle, indicating alterations of the cell wall. Biochemical analysis indicated that the altered cell wall properties of WIII‐pbpB might contribute to the positive effect on sterol utilization. The productivity of 4‐HBC was enhanced by 28% in the WIII‐pbpB strain compared to that of WIII. These results demonstrated that the modification of peptidoglycan synthesis can improve the conversion of sterols to steroid synthons in mycobacteria. 相似文献
147.
Masato Asaoka Eri Hagiwara Satoshi Etori Katsuyuki Higa Satoshi Ikeda Akimasa Sekine Hideya Kitamura Tomohisa Baba Shigeru Komatsu Takashi Ogura 《Internal medicine (Tokyo, Japan)》2021,60(20):3213
Objective Although multiple nontuberculous mycobacteria (NTM) species can be isolated from the same patient, little has been reported on co-isolation. We clarified the trends and characteristics of the co-isolation of multiple NTM species. Methods To collect data on multiple NTM isolation, we first extracted all patients who visited our hospital from 2006 through 2015 with a diagnosis of NTM lung diseases other than Mycobacterium avium complex (MAC) and then reviewed their medical records to evaluate the co-isolation of multiple NTM species. Results Of 213 patients with non-MAC lung disease, the most common NTM species was M. gordonae (32%), followed by M. kansasii (20%) and M. abscessus (14%). Non-MAC NTM lung disease tended to be associated with middle age with a low body mass index and male predominance. Multiple NTM species were isolated from 55 (26%) of the 213 patients. The clinical characteristics associated with multiple NTM species isolation included female predominance, never smokers and the absence of cavity lesions in the lungs. The highest co-isolation rate was observed in patients with M. gordonae isolation (30%), followed by M. furtuitum isolation (26%) and M. abscessus isolation (20%). Only MAC was isolated when co-isolated with M. abscessus. Among M. szulgai, M. peregrinum and M. terrae isolation, no other NTM species were detected. Conclusion Co-isolation of multiple NTM species was not uncommon, with 26% of patients with non-MAC NTM lung diseases showing co-isolation with multiple NTM species. Each NTM species had distinct characteristics in terms of co-isolation. 相似文献
148.
149.
Taiji Koyama Yohei Funakoshi Yoshinori Imamura Sho Nishimura Yoshimi Fujishima Masanori Toyoda Naomi Kiyota Hirokazu Tanino Hironobu Minami 《Internal medicine (Tokyo, Japan)》2021,60(21):3485
Treatment with anti-programmed cell death-1 (PD-1) antibodies improves the anti-cancer immune response and can provide a meaningful clinical benefit to cancer patients. However, this treatment can result in specific autoimmune toxicities, termed immune-related adverse events (irAEs). Although irAEs are well recognized, the development of infectious diseases due to this treatment is not often observed. Some recent reports have indicated that patients who receive anti-PD-1 antibodies are at a higher risk for tuberculosis than others. However, reports on nontuberculous mycobacterial infection during anti-PD-1 antibody treatment are still rare. We herein report the first case of Mycobacterium mageritense infection during anti-PD-1 antibody treatment. 相似文献
150.
A workshop discussing eight clusters of hypersensitivity pneumonitis in the automotive industry among metalworking fluid-exposed workers concluded that a risk exists for this granulomatous lung disease where water-based fluids are used and unusual microbial contaminants predominate. Strong candidates for microbial etiology are nontuberculous mycobacteria and fungi. Cases of hypersensitivity pneumonitis occur among cases with other work-related respiratory symptoms and chest diseases. Reversibility of disease has occurred in many cases with exposure cessation, allowing return to work to jobs without metalworking fluid exposures or, in some situations, to jobs without the same metalworking fluid exposures. Cases have been recognized with metalworking fluid exposures generally less than 0.5 mg/m3. The workshop participants identified knowledge gaps regarding risk factors, exposure-response relationships, intervention efficacy, and natural history, as well as surveillance needs to define the extent of the problem in this industry. In the absence of answers to these questions, guidance for prevention is necessarily limited. Am. J. Ind. Med. 32:423ndash;432, 1997. © 1997 Wiley-Liss, Inc. 相似文献